Prevalence and incidence of systemic lupus erythematosus in the adult population of Estonia.

Abstract:

:Studies have demonstrated considerable variability in systemic lupus erythematosus (SLE) incidence and prevalence estimates. Lack of reliable epidemiological data may hinder evidence-based health care planning. The aim of the present study was to estimate the prevalence and incidence of SLE in the Estonian adult population. The SLE billing cases were extracted from the Estonian Health Insurance Fund database 2006-2010 and verified using health care providers' databases. The patients' life status data for January 1, 2011, were retrieved from the Estonian Population Register. The calculations for the estimates' lower limits were based on verified cases only; the upper limits calculations also accounted for the billing cases for which clinical data were unavailable. The period prevalence of SLE was between 39 and 48 per 100,000 and incidence rate between 1.5 and 1.8 per 100,000 person-years. The point prevalence on January 1, 2011, was between 37 and 40 per 100,000. The estimates are comparable with internationally published figures and can be used to enhance evidence-based health care planning. The high percentage of billing cases that could not be verified using clinical data supports the argument that epidemiological studies based solely on administrative databases are usually of low reliability.

journal_name

Lupus

journal_title

Lupus

authors

Otsa K,Talli S,Harding P,Parsik E,Esko M,Teepere A,Tammaru M

doi

10.1177/0961203316686705

subject

Has Abstract

pub_date

2017-09-01 00:00:00

pages

1115-1120

issue

10

eissn

0961-2033

issn

1477-0962

journal_volume

26

pub_type

杂志文章

相关文献

LUPUS文献大全
  • The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity.

    abstract::This study investigates specificity, sensitivity and concomitant presence of antibodies against histone H1 (H1), nucleosomes (NUC), chromatin (CHR) and dsDNA in patients with systemic lupus erythematosus (SLE), analyses their association with SLE disease activity and characterizes the immunodominant epitope reactivity...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203302lu247oa

    authors: Schett G,Smole J,Zimmermann C,Hiesberger H,Hoefler E,Fournel S,Muller S,Rubin RL,Steiner G

    更新日期:2002-01-01 00:00:00

  • The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus.

    abstract::Antiphospholipid syndrome (APS), as a primary disease or a secondary syndrome in systemic lupus erythematosus (SLE), is characterized by the presence of antiphospholipid antibodies (aPL) and a clinical event. It is likely that both genetic and environmental factors lead to the development of aPL and progression to dis...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314548248

    authors: Salem D,Subang R,Laplante P,Levine JS,Rauch J

    更新日期:2014-10-01 00:00:00

  • Systemic lupus erythematosus in three ethnic groups: XV. Prevalence and correlates of fibromyalgia.

    abstract::The purpose of this study was to determine the prevalence and correlates of fibromyalgia (FM) in a prospective, multiethnic systemic lupus (SLE) cohort. A total of 266 SLE patients with disease duration of < or = 5 years at study entry were evaluated longitudinally for the presence of FM (per ACR criteria). Sociodemog...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu330oa

    authors: Friedman AW,Tewi MB,Ahn C,McGwin G Jr,Fessler BJ,Bastian HM,Baethge BA,Reveille JD,Alarcón GS,LUMINA Study Group.

    更新日期:2003-01-01 00:00:00

  • Annexin A2: biology and relevance to the antiphospholipid syndrome.

    abstract::Antiphospholipid antibodies (aPL), the majority of which are directed against beta(2)-glycoprotein I (beta(2)GPI), are associated with an increased incidence of venous and arterial thrombosis. The pathogenesis of antiphospholipid/anti-beta(2)GPI-associated thrombosis has not been defined, and is likely multifactorial....

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203308095329

    authors: Cockrell E,Espinola RG,McCrae KR

    更新日期:2008-10-01 00:00:00

  • Autoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies.

    abstract::Criteria of organ-specific autoimmunity are fulfilled in a subset of patients with myocarditis/dilated cardiomyopathy (DCM). In particular, circulating heart-reactive autoantibodies are found in patients and symptom-free relatives. These autoantibodies are directed against multiple antigens, some of which are expresse...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203305lu2193oa

    authors: Caforio AL,Daliento L,Angelini A,Bottaro S,Vinci A,Dequal G,Tona F,Iliceto S,Thiene G,McKenna WJ

    更新日期:2005-01-01 00:00:00

  • Striking alteration of some populations of T/B cells in systemic lupus erythematosus: relationship to expression of CD62L or some chemokine receptors.

    abstract::Recent studies have revealed new populations of T/B cells, including central/effector memory, follicular T cells and CXCR3+ or CXCR4+ B cells. In the present study, changes in these populations of CD4+ T cells were examined on the basis of the expression of CD62L, CCR7 and CXCR5 in patients with systemic lupus erythem...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307085246

    authors: Watanabe T,Suzuki J,Mitsuo A,Nakano S,Tamayama Y,Katagiri A,Amano H,Morimoto S,Tokano Y,Takasaki Y

    更新日期:2008-01-01 00:00:00

  • Renal transplantation for lupus nephritis: non-adherence and graft survival.

    abstract:OBJECTIVES:Poor adherence to immunosuppressive treatment is common in patients with systemic lupus erythematosus and may identify those with lupus nephritis (LN) who have a poorer prognosis. Non-adherence has also been reported to be a potential adverse outcome predictor in renal transplantation (rTp). We investigated ...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203319842641

    authors: Ntatsaki E,Vassiliou VS,Velo-Garcia A,Salama AD,Isenberg DA

    更新日期:2019-04-01 00:00:00

  • Urinary high-mobility group box-1 associates specifically with lupus nephritis class V.

    abstract:INTRODUCTION:High-mobility group box 1 protein (HMGB-1) has been implicated in the pathogenesis of lupus nephritis (LN). There is increased HMGB-1 expression in the kidneys and increased levels are observed in serum and urine of patients with LN. This study was performed to determine whether the increased urinary HMGB-...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316644331

    authors: Jog NR,Blanco I,Lee I,Putterman C,Caricchio R

    更新日期:2016-12-01 00:00:00

  • Antiphospholipid antibodies and myocardial infarction.

    abstract::In prospective studies, increased levels of cardiolipin-biding antibodies and autoantibodies to oxidized low-density lipoprotein (LDL) have been observed in patients with myocardial infarction (MI). These findings suggest that antiphospholipid antibodies may contribute to the development of MI. The 'oxidative-modifica...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339800700229

    authors: Vaarala O

    更新日期:1998-01-01 00:00:00

  • Hypercatabolism of IgG in mice with lupus-like syndrome.

    abstract::The metabolism of radioiodinated mouse IgG was studied in mice with lupus-like syndrome before and after the onset of the disease. Before the onset of the disease, the pharmacokinetic parameters of IgG in MLR-1pr and Pristane-primed Balb/c mice were within the normal range of values. After the onset of the disease a c...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203305lu2129oa

    authors: Zhou J,Pop LM,Ghetie V

    更新日期:2005-01-01 00:00:00

  • Deciphering systemic lupus erythematosus-associated serum biomarkers reflecting apoptosis and disease activity.

    abstract::Systemic lupus erythematosus (SLE) is a severe chronic inflammatory autoimmune connective tissue disease. Despite major efforts, SLE remains a poorly understood disease with unpredictable course, unknown etiology and complex pathogenesis. Apoptosis combined with deficiency in clearing apoptotic cells is an important e...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316669240

    authors: Delfani P,Sturfelt G,Gullstrand B,Carlsson A,Kassandra M,Borrebaeck CA,Bengtsson AA,Wingren C

    更新日期:2017-04-01 00:00:00

  • Swallowing disturbance due to isolated vagus nerve involvement in systemic lupus erythematosus.

    abstract::Neuropsychiatric lupus is a well-recognized complication of systemic lupus erythematosus (SLE) and encompasses a wide variety of neurological manifestations. Although isolated cranial nerve involvement is rare, it can cause significant morbidity and disability. This report describes a case with isolated vagus nerve in...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307080632

    authors: Yu KH,Yang CH,Chu CC

    更新日期:2007-01-01 00:00:00

  • Infant perinatal thrombosis and antiphospholipid antibodies: a review.

    abstract::Perinatal thrombosis in infants born to mothers with antiphospholipid antibodies (aPL) is a rare event, but with risk of death or severe sequelae. We analysed 16 infants with such perinatal thrombosis reported in the literature in the last 20 years. Thromboses were arterial (13/16), mostly strokes (8/16). Hydrops feta...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203307079039

    authors: Boffa MC,Lachassinne E

    更新日期:2007-01-01 00:00:00

  • Impact of markers of endothelial injury and hypercoagulability on systemic lupus erythematosus.

    abstract::We have explored the relationship between possible hemostatic changes and clinical manifestation of the systemic lupus erythematosus (SLE) as a function of greater or lesser disease activity according to Systemic Lupus Erythematosus Disease Activity Index-2000 (SLEDAI-2K) criteria. Endothelial injury and hypercoagulab...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319899478

    authors: Cicarini WB,Duarte RCF,Ferreira KS,Loures CMG,Consoli RV,Neiva CLS,de Pádua PM,Nunes FFC,Alves LCV,Reis EA,Moreira CC,Guimarães TMPD,de Toledo VPCP,Carvalho MDG

    更新日期:2020-02-01 00:00:00

  • Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo.

    abstract::In a 76-week, randomized controlled trial, patients received 100 mg LJP 394 or placebo weekly for 16 weeks followed by three 12-week treatment cycles of 50 mg LJP 394 or placebo weekly each separated by eight-week periods when no therapy was administered. Health-related quality of life (HRQOL) was assessed using SF-36...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1191/0961203303lu440oa

    authors: Strand V,Aranow C,Cardiel MH,Alarcón-Segovia D,Furie R,Sherrer Y,Tumlin J,Wallace DJ,Crawford B,LJP 394 Investigator Consortium.

    更新日期:2003-01-01 00:00:00

  • High-dose cyclophosphamide for severe systemic lupus erythematosus.

    abstract::Cytotoxic therapy is a cornerstone for patients with severe systemic lupus erythematosus (SLE). High-dose cyclophosphamide, 200 mg/kg, can induce a complete remission without the need for stem cell rescue in patients with autoimmune illnesses. Here we report on our first four patients treated for severe SLE with this ...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章

    doi:10.1191/0961203302lu229oa

    authors: Gladstone DE,Prestrud AA,Pradhan A,Styler MJ,Topolsky DL,Crilley PA,Hoch S,Huppert A,Brodsky I

    更新日期:2002-01-01 00:00:00

  • Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.

    abstract::Congenital heart block occurs in fetuses of Ro/SSA and La/SSB positive women. To investigate the stability of maternal autoantibody levels during pregnancy, we followed Ro52, Ro60 and La autoantibody IgG level variation and Ro52 subclass profiles longitudinally in selected congenital heart block risk pregnancies. Seru...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203306lu2309oa

    authors: Strandberg L,Salomonsson S,Bremme K,Sonesson S,Wahren-Herlenius M

    更新日期:2006-01-01 00:00:00

  • From rheumatic fever to Libman-Sacks endocarditis: is there any possible pathogenetic link?

    abstract::The heart lesions of rheumatic fever and the heart involvement in antiphospholipid syndrome (APS), have different clinical pictures. Yet, there are several common characteristics linking both diseases: 1) central nervous system (CNS) and heart involvement; 2) molecular mimicry between the a pathogen and the origin of ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203305lu2203oa

    authors: Blank M,Aron-Maor A,Shoenfeld Y

    更新日期:2005-01-01 00:00:00

  • Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome.

    abstract::The aim of this study was to evaluate traditional risk factors for coronary artery disease (CAD), homocysteine, anti-oxidized low-density lipoprotein (anti-oxLDL), anti-lipoprotein lipase (anti-LPL) and endothelin-1 (ET-1) in patients with primary anti-phospholipid syndrome (APS), furthermore verify possible associati...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307081847

    authors: de Souza AW,Silva NP,de Carvalho JF,D'Almeida V,Noguti MA,Sato EI

    更新日期:2007-01-01 00:00:00

  • European registry of babies born to mothers with antiphospholipid syndrome: a result update.

    abstract::The registry is a prospective, European, multicentric, longitudinal study, which follows a cohort of children born to mothers with antiphospholipid syndrome (APS). It was started in 2003. In this report, we update the results obtained from the study of 110 mothers and 112 children (two twin births). Eighty per cent of...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203309106951

    authors: Boffa MC,Lachassinne E,Boinot C,De Carolis S,Rovere-Querini P,Avcin T,Biasini-Rebaioli C,Le Toumelin P,Aurousseau MH,Tincani A

    更新日期:2009-09-01 00:00:00

  • Lupus nephritis in Croatian children: clinicopathologic findings and outcome.

    abstract::We report clinical and histopathological features, treatment and outcome of 37 Croatian children with biopsy-proven lupus nephritis seen over a 30-year period. The mean age at lupus nephritis presentation was 12.11 ± 2.59 years (range 4.66-17.0). The most frequent histopathological finding was class IV (37.8%), follow...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314563133

    authors: Batinić D,Milošević D,Čorić M,Topalović-Grković M,Jelušić M,Turudić D

    更新日期:2015-03-01 00:00:00

  • Sexual dysfunction in Egyptian females with systemic lupus erythematosus: a cross sectional study.

    abstract:OBJECTIVES:Sexual dysfunction in systemic lupus erythematous (SLE) patients is an important issue to be tackled. We aimed to study the prevalence of sexual dysfunction in SLE women and detect its association with depression, functional disability and quality of life. METHODS:This study included 94 SLE females. Ninety-...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320935518

    authors: Dorgham D,Haggag HM,Attia DH

    更新日期:2020-08-01 00:00:00

  • Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus.

    abstract::Twelve systemic lupus erythematosus (SLE) patients with mild to moderate disease activity (SLEDAI of > or = 6 and on prednisolone < 0.5 mg/kg/day) were included in a prospective, randomized, double-blind, placebo-controlled pilot study for 24 weeks. Six were randomized to receive oral leflunomide and six received plac...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1191/0961203304lu1067sr

    authors: Tam LS,Li EK,Wong CK,Lam CW,Szeto CC

    更新日期:2004-01-01 00:00:00

  • DNA methylation in systemic lupus erythematosus.

    abstract::Recent studies on epigenetics, including DNA methylation and its regulatory enzymes, seem likely to contribute to elucidation of the pathogenesis of autoimmune diseases such as systemic lupus erythematosus (SLE), although the relationship between DNA methylation and SLE has long been the subject of investigation. To o...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203303lu321oa

    authors: Sekigawa I,Okada M,Ogasawara H,Kaneko H,Hishikawa T,Hashimoto H

    更新日期:2003-01-01 00:00:00

  • Analysis of clinical and laboratory profile in Indian childhood systemic lupus erythematosus and its comparison with SLE in adults.

    abstract::Data on the clinical and laboratory profiles of 83 children with SLE have been analysed and compared with data on 187 adults with the disease. The clinical features of childhood SLE are similar to those seen in adults, although clinical and laboratory parameters reflect propensity to a more severe form of the disease ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339300200204

    authors: Pande I,Sekharan NG,Kailash S,Uppal SS,Singh RR,Kumar A,Malaviya AN

    更新日期:1993-04-01 00:00:00

  • Reflections on the management of reproductive failure in the antiphospholipid syndrome--the clinician's perspective.

    abstract::It is well known that women with systemic lupus erythematosus (SLE) who have antiphospholipid antibodies (aPL) are at increased risk for pregnancy loss. Additionally, other reproductive processes, such as unexplained infertility and implantation failure after in vitro fertilization and embryo transfer may be affected ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203302lu237ra

    authors: Balasch J,Cervera R

    更新日期:2002-01-01 00:00:00

  • Cognitive dysfunction in SLE: development of a screening tool.

    abstract:BACKGROUND:Cognitive dysfunction (CD) is among the most common neuropsychiatric manifestations of systemic lupus erythematosus (SLE). There are two methods which have been used to detect CD in patients with SLE: traditional neuropsychological tests (NPT) and the Automated Neuropsychological Assessment Metrics (ANAM). B...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311405374

    authors: Adhikari T,Piatti A,Luggen M

    更新日期:2011-10-01 00:00:00

  • Factors associated with increased white matter hyperintense lesion (WMHI) load in patients with systemic lupus erythematosus (SLE).

    abstract::Introduction White matter hyperintense (WMHI) lesions are the most common finding in magnetic resonance imaging (MRI) of the brain in patients with systemic lupus erythematosus (SLE). Objective The objective of this article is to determine the clinical factors associated with an increase in WMHI lesion load among SLE ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317707062

    authors: Shaharir SS,Osman SS,Md Rani SA,Sakthiswary R,Said MSM

    更新日期:2018-01-01 00:00:00

  • Mycophenolate mofetil in nonlupus glomerulonephropathy.

    abstract::Mycophenolate mofetil (MMF) initially found widespread use in the immunoprophylaxis of rejection in organ transplantation. It has subsequently been used in lupus glomerulonephritis, where early studies have shown it to be effective in induction and maintenance therapy. The randomized studies have mostly studied small ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203305lu2116oa

    authors: Karim MY,Abbs IC

    更新日期:2005-01-01 00:00:00

  • Pathological manifestation of autoimmune myocarditis is detected prior to glomerulonephritis in a murine model of lupus nephritis.

    abstract:OBJECTIVE:Since enhanced cardiac magnetic resonance imaging (cMRI) signals have been associated with lupus disease activity in humans prior to renal failure and novel, cardiac-focused therapeutic strategies could be investigated with an associated animal model, autoimmune myocarditis was characterized in murine lupus n...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320948959

    authors: Young NA,Jablonski K,Schwarz E,Okafor I,Hampton J,Valiente GR,Henry C,Harb P,Barger J,Bratasz A,Kalyanasundaram A,Ardoin SP,Jarjour WN

    更新日期:2020-11-01 00:00:00